Achmea Investment Management B.V. grew its stake in Varian Medical Systems, Inc. (NYSE:VAR) by 5.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 12,702 shares of the medical equipment provider’s stock after buying an additional 701 shares during the period. Achmea Investment Management B.V.’s holdings in Varian Medical Systems were worth $1,439,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. JLB & Associates Inc. lifted its position in shares of Varian Medical Systems by 0.7% in the fourth quarter. JLB & Associates Inc. now owns 81,621 shares of the medical equipment provider’s stock worth $9,248,000 after buying an additional 528 shares during the last quarter. Burney Co. lifted its position in shares of Varian Medical Systems by 6.0% in the fourth quarter. Burney Co. now owns 33,780 shares of the medical equipment provider’s stock worth $3,828,000 after buying an additional 1,915 shares during the last quarter. Fox Run Management L.L.C. acquired a new position in shares of Varian Medical Systems during the 4th quarter worth about $1,219,000. Resources Management Corp CT ADV acquired a new position in shares of Varian Medical Systems during the 3rd quarter worth about $111,000. Finally, Polar Capital LLP acquired a new position in shares of Varian Medical Systems during the 4th quarter worth about $28,824,000. 91.95% of the stock is owned by institutional investors.

In related news, CAO Magnus Momsen sold 2,800 shares of the business’s stock in a transaction dated Thursday, January 3rd. The stock was sold at an average price of $110.17, for a total transaction of $308,476.00. Following the transaction, the chief accounting officer now directly owns 3,281 shares in the company, valued at $361,467.77. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Kolleen T. Kennedy sold 6,462 shares of the business’s stock in a transaction dated Friday, January 11th. The shares were sold at an average price of $125.00, for a total value of $807,750.00. Following the transaction, the executive vice president now owns 26,898 shares in the company, valued at $3,362,250. The disclosure for this sale can be found here. Insiders have sold 47,466 shares of company stock worth $6,105,577 over the last 90 days. Corporate insiders own 0.74% of the company’s stock.

NYSE VAR opened at $136.60 on Friday. Varian Medical Systems, Inc. has a twelve month low of $101.42 and a twelve month high of $137.67. The stock has a market cap of $12.35 billion, a P/E ratio of 30.90, a price-to-earnings-growth ratio of 3.60 and a beta of 0.85.

Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings results on Wednesday, January 23rd. The medical equipment provider reported $1.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.01). Varian Medical Systems had a net margin of 12.28% and a return on equity of 26.18%. The firm had revenue of $741.00 million for the quarter, compared to the consensus estimate of $717.83 million. During the same quarter in the prior year, the firm earned $1.06 earnings per share. The company’s revenue was up 9.2% on a year-over-year basis. Analysts forecast that Varian Medical Systems, Inc. will post 4.7 earnings per share for the current fiscal year.

Several equities analysts recently weighed in on the company. Barrington Research reissued a “buy” rating on shares of Varian Medical Systems in a research report on Thursday, January 24th. Jefferies Financial Group boosted their price objective on Varian Medical Systems to $145.00 and gave the stock a “buy” rating in a research report on Thursday, January 24th. Royal Bank of Canada boosted their price objective on Varian Medical Systems to $130.00 and gave the stock a “sector perform” rating in a research report on Thursday, January 24th. Zacks Investment Research raised Varian Medical Systems from a “hold” rating to a “strong-buy” rating and set a $146.00 price objective for the company in a research report on Saturday, January 26th. Finally, BTIG Research reissued a “hold” rating on shares of Varian Medical Systems in a research report on Thursday, January 24th. One analyst has rated the stock with a sell rating, three have given a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. Varian Medical Systems presently has a consensus rating of “Buy” and a consensus price target of $130.63.

ILLEGAL ACTIVITY NOTICE: This report was first posted by Watch List News and is the property of of Watch List News. If you are reading this report on another domain, it was stolen and republished in violation of international copyright law. The original version of this report can be read at https://www.watchlistnews.com/achmea-investment-management-b-v-has-1-44-million-holdings-in-varian-medical-systems-inc-var/2896177.html.

Varian Medical Systems Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.

Read More: What is a Leveraged Buyout (LBO)?

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.